Here at PhotoSound Technologies, Inc Technologies, we are proud to announce that the TriTom, Small Animal Whole Body In Vivo Imaging system based on PhotoAcoustic Fluorescence Tomography, has been placed in the The University of Texas MD Anderson Cancer Center in Houston, Texas. MD Anderson is one of the most respected names of cancer research that is devoted to cancer patient care, research, education and prevention.
The TriTom imaging system has a broad spectrum of preclinical research applications ranging from cancer, toxicology, developmental biology to tissue engineering and regeneration. The TriTom platform is based on Photoacoustic Fluorescence Tomography (PAFT) technology that provides unparalleled capabilities for whole-body imaging and in vivo characterization of small animal models. Complimentary 3D imaging modalities are integrated into a single powerful instrument by enabling co-registered Photoacoustic Tomography and Fluorescence Molecular Tomography. Combining high-resolution photoacoustic imaging with high contrast fluorescence optical tomography allows deep tissue imaging, superior molecular sensitivity, and 3D localization of anatomical, functional, and molecular data.
MD Anderson’s mission is to eliminate cancer in Texas, the nation and the world through exceptional programs that integrate patient care, research, and prevention. Collaborating with MD Anderson will allow insights from vast quantities of data while assuring appropriate use of all products. This achievement is in hindsight, with hopes of scientific advancements that can lead to potential therapies for diseases such as cancer. Due to the close proximity of the two locations, the partnership allows testing to be conducted while enabling new products and software to be tested quickly and accurately.